Kinetics of HCV envelope proteins' interaction with CD81 large extracellular loop

Biochemical and Biophysical Research Communications

Volumn 328, Issue 4, 2005, Pages 1091-1100

  Nakajima, Hideki ^a   Cocquerel, Laurence ^a   Kiyokawa, Nobutaka ^b   Fujimoto, Junichiro ^b   Levy, Shoshana ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

CD81; Hepatitis C virus; Kinetics; Surface plasmon resonance; Tetraspanin

Indexed keywords

CD81 ANTIGEN; DISULFIDE; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN E1; HYBRID PROTEIN; LIGAND; MALTOSE BINDING PROTEIN; MONOMER; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; BIOLOGICAL MONITORING; BIOSENSOR; CELL KINETICS; CONTROLLED STUDY; COVALENT BOND; DISSOCIATION CONSTANT; EXTRACELLULAR MATRIX; HEPATITIS C VIRUS; INJECTION; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION;

EID: 13744251677     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.01.056     Document Type: Article

References (50)

1. WHO, Hepatitis C, Wkly Epidemiol. Record 72 (1997) 65-69
2. M. Houghton Hepatitis C viruses third ed. D.M. Knipe P.M. Howley Fields virology 1996 Lippincott-Raven Publishers Phiradelphia, PA 1035 1058
3. W.K. Weng, and S. Levy Hepatitis C virus (HCV) and lymphomagenesis Leuk. Lymphoma 44 2003 1113 1120
4. A. Grakoui, C. Wychowski, C. Lin, S.M. Feinstone, and C.M. Rice Expression and identification of hepatitis C virus polyprotein cleavage products J. Virol. 67 1993 1385 1395
5. A. Op De Beeck, L. Cocquerel, and J. Dubuisson Biogenesis of hepatitis C virus envelope glycoproteins J. Gen. Virol. 82 2001 2589 2595
6. J. Dubuisson Folding, assembly and subcellular localization of hepatitis C virus glycoproteins Curr. Top. Microbiol. Immunol. 242 2000 135 148
7. M. Flint, C. Maidens, L.D. Loomis-Price, C. Shotton, J. Dubuisson, P. Monk, A. Higginbottom, S. Levy, and J.A. McKeating Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81 J. Virol. 73 1999 6235 6244
8. P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A.J. Weiner, M. Houghton, D. Rosa, G. Grandi, and S. Abrignani Binding of hepatitis C virus to CD81 Science 282 1998 938 941
9. M. Lambot, S. Fretier, A. Op DeBeeck, B. Quatannens, S. Lestavel, V. Clavey, and J. Dubuisson Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment J. Biol. Chem. 277 2002 20625 20630
10. S. Wellnitz, B. Klumpp, H. Barth, S. Ito, E. Depla, J. Dubuisson, H.E. Blum, and T.F. Baumert Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines J. Virol. 76 2002 1181 1193
11. M. Lechmann, K. Murata, J. Satoi, J. Vergalla, T.F. Baumert, and T.J. Liang Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice Hepatology 34 2001 417 423
12. T.F. Baumert, S. Ito, D.T. Wong, and T.J. Liang Hepatitis C virus structural proteins assemble into virus like particles in insect cells J. Virol. 72 1998 3827 3836
13. B. Bartosch, J. Dubuisson, and F.L. Cosset Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes J. Exp. Med. 197 2003 633 642
14. M. Hsu, J. Zhang, M. Flint, C. Logvinoff, C. Cheng-Mayer, C.M. Rice, and J.A. McKeating Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles Proc. Natl. Acad. Sci. USA 100 2003 7271 7276
15. B. Bartosch, A. Vitelli, C. Granier, C. Goujon, J. Dubuisson, S. Pascale, E. Scarselli, R. Cortese, A. Nicosia, and F.L. Cosset Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor J. Biol. Chem. 278 2003 41624 41630
16. A. Op De Beeck, C. Voisset, B. Bartosch, Y. Ciczora, L. Cocquerel, Z. Keck, S. Foung, F.L. Cosset, and J. Dubuisson Characterization of functional hepatitis C virus envelope glycoproteins J. Virol. 78 2004 2994 3002
17. E.G. Cormier, F. Tsamis, F. Kajumo, R.J. Durso, J.P. Gardner, and T. Dragic CD81 is an entry coreceptor for hepatitis C virus Proc. Natl. Acad. Sci. USA 101 2004 7270 7274
18. S. Levy, S.C. Todd, and H.T. Maecker CD81 (TAPA-1): A molecule involved in signal transduction and cell adhesion in the immune system Annu. Rev. Immunol. 16 1998 89 109
19. C. Boucheix, and E. Rubinstein Tetraspanins Cell. Mol. Life Sci. 58 2001 1189 1205
20. C.S. Stipp, T.V. Kolesnikova, and M.E. Hemler Functional domains in tetraspanin proteins Trends Biochem. Sci. 28 2003 106 112
21. E. Rubinstein, F. Le Naour, C. Lagaudriere-Gesbert, M. Billard, H. Conjeaud, and C. Boucheix CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins Eur. J. Immunol. 26 1996 2657 2665
22. K.D. Little, M.E. Hemler, and C.S. Stipp Dynamic regulation of a GPCR-tetraspanin-G protein complex on intact cells: Central role of CD81 in facilitating GPR56-G{ralpha}q/11 association Mol. Biol. Cell 15 2004 2373 2387
23. M. Seigneuret, A. Delaguillaumie, C. Lagaudriere-Gesbert, and H. Conjeaud Structure of the tetraspanin main extracellular domain. A partially conserved fold with a structurally variable domain insertion J. Biol. Chem. 276 2001 40055 40064
24. M.E. Hemler Specific tetraspanin functions J. Cell Biol. 155 2001 1103 1107
25. K. Kitadokoro, M. Ponassi, G. Galli, R. Petracca, F. Falugi, G. Grandi, and M. Bolognesi Subunit association and conformational flexibility in the head subdomain of human CD81 large extracellular loop Biol. Chem. 383 2002 1447 1452
26. K. Kitadokoro, G. Galli, R. Petracca, F. Falugi, G. Grandi, and M. Bolognesi Crystallization and preliminary crystallographic studies on the large extracellular domain of human CD81, a tetraspanin receptor for hepatitis C virus Acta Crystallogr. D. Biol. Crystallogr. 57 2001 156 158
27. R. Petracca, F. Falugi, G. Galli, N. Norais, D. Rosa, S. Campagnoli, V. Burgio, E. Di Stasio, B. Giardina, M. Houghton, S. Abrignani, and G. Grandi Structure-function analysis of hepatitis C virus envelope-CD81 binding J. Virol. 74 2000 4824 4830
28. K. Matsui, J.J. Boniface, P. Steffner, P.A. Reay, and M.M. Davis Kinetics of T-cell receptor binding to peptide/I-Ek complexes: Correlation of the dissociation rate with T-cell responsiveness Proc. Natl. Acad. Sci. USA 91 1994 12862 12866
29. L. Cocquerel, C.C. Kuo, J. Dubuisson, and S. Levy CD81-dependent binding of hepatitis C virus E1E2 heterodimers J. Virol. 77 2003 10677 10683
30. S. Takahashi, C. Doss, S. Levy, and R. Levy TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen J. Immunol. 145 1990 2207 2213
31. V. Deleersnyder, A. Pillez, C. Wychowski, K. Blight, J. Xu, Y.S. Hahn, C.M. Rice, and J. Dubuisson Formation of native hepatitis C virus glycoprotein complexes J. Virol. 71 1997 697 704
32. L. Cocquerel, J.C. Meunier, A. Pillez, C. Wychowski, and J. Dubuisson A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2 J. Virol. 72 1998 2183 2191
33. A. Higginbottom, E.R. Quinn, C.C. Kuo, M. Flint, L.H. Wilson, E. Bianchi, A. Nicosia, P.N. Monk, J.A. McKeating, and S. Levy Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2 J. Virol. 74 2000 3642 3649
34. E.R. Quinn, C.H. Chan, K.G. Hadlock, S.K. Foung, M. Flint, and S. Levy The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis Blood 98 2001 3745 3749
35. M. Flint, J. Dubuisson, C. Maidens, R. Harrop, G.R. Guile, P. Borrow, and J.A. McKeating Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein J. Virol. 74 2000 702 709
36. M. Triyatni, B. Saunier, P. Maruvada, A.R. Davis, L. Ulianich, T. Heller, A. Patel, L.D. Kohn, and T.J. Liang Interaction of hepatitis C virus-like particles and cells: A model system for studying viral binding and entry J. Virol. 76 2002 9335 9344
37. R. Roccasecca, H. Ansuini, A. Vitelli, A. Meola, E. Scarselli, S. Acali, M. Pezzanera, B.B. Ercole, J. McKeating, A. Yagnik, A. Lahm, A. Tramontano, R. Cortese, and A. Nicosia Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2 J. Virol. 77 2003 1856 1867
38. L. Cocquerel, E.R. Quinn, M. Flint, K.G. Hadlock, S.K. Foung, and S. Levy Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody J. Virol. 77 2003 1604 1609
39. H.E. Drummer, K.A. Wilson, and P. Poumbourios Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81 J. Virol. 76 2002 11143 11147
40. R.B. Kapust, and D.S. Waugh Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused Protein Sci. 8 1999 1668 1674
41. M.B. Khalifa, L. Choulier, H. Lortat-Jacob, D. Altschuh, and T. Vernet BIACORE data processing: An evaluation of the global fitting procedure Anal. Biochem. 293 2001 194 203
42. G. De Crescenzo, S. Grothe, R. Lortie, M.T. Debanne, and M. O'Connor-McCourt Real-time kinetic studies on the interaction of transforming growth factor alpha with the epidermal growth factor receptor extracellular domain reveal a conformational change model Biochemistry 39 2000 9466 9476
43. R. Karlsson, and A. Falt Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors J. Immunol. Methods 200 1997 121 133
44. T. Allander, X. Forns, S.U. Emerson, R.H. Purcell, and J. Bukh Hepatitis C virus envelope protein E2 binds to CD81 of tamarins Virology 277 2000 358 367
45. A. Meola, A. Sbardellati, B. Bruni Ercole, M. Cerretani, M. Pezzanera, A. Ceccacci, A. Vitelli, S. Levy, A. Nicosia, C. Traboni, J. McKeating, and E. Scarselli Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection J. Virol. 74 2000 5933 5938
46. B. Maschera, G. Darby, G. Palu, L.L. Wright, M. Tisdale, R. Myers, E.D. Blair, and E.S. Furfine Human immunodeficiency virus. Mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease-saquinavir complex J. Biol. Chem. 271 1996 33231 33235
47. L. Cocquerel, J.C. Meunier, A. Op de Beeck, D. Bonte, C. Wychowski, and J. Dubuisson Coexpression of hepatitis C virus envelope proteins E1 and E2 in cis improves the stability of membrane insertion of E2 J. Gen. Virol. 82 2001 1629 1635
48. K. Kitadokoro, D. Bordo, G. Galli, R. Petracca, F. Falugi, S. Abrignani, G. Grandi, and M. Bolognesi CD81 extracellular domain 3D structure: Insight into the tetraspanin superfamily structural motifs EMBO J. 20 2001 12 18
49. A.T. Yagnik, A. Lahm, A. Meola, R.M. Roccasecca, B.B. Ercole, A. Nicosia, and A. Tramontano A model for the hepatitis C virus envelope glycoprotein E2 Proteins 40 2000 355 366
50. O.V. Kovalenko, X. Yang, T.V. Kolesnikova, and M.E. Hemler Evidence for specific tetraspanin homodimers: inhibition of palmitoylation makes cysteine residues available for cross-linking Biochem. J. 377 2004 407 417